Cargando…
Contribution of Uptake and Efflux Transporters to Oral Pharmacokinetics of Furosemide
[Image: see text] Furosemide is a widely used diuretic for treating excessive fluid accumulation caused by disease conditions like heart failure and liver cirrhosis. Furosemide tablet formulation exhibits variable pharmacokinetics (PK) with bioavailability ranging from 10 to almost 100%. To explain...
Autores principales: | Chapa, Revathi, Li, Cindy Yanfei, Basit, Abdul, Thakur, Aarzoo, Ladumor, Mayur K, Sharma, Sheena, Singh, Saranjit, Selen, Arzu, Prasad, Bhagwat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774078/ https://www.ncbi.nlm.nih.gov/pubmed/33403255 http://dx.doi.org/10.1021/acsomega.0c03930 |
Ejemplares similares
-
A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) modelling and simulation
por: Ladumor, Mayur K., et al.
Publicado: (2019) -
Interplay of Breast Cancer Resistance Protein (Bcrp/Abcg2), Sex, and Fed State in Oral Pharmacokinetic Variability of Furosemide in Rats
por: Sharma, Sheena, et al.
Publicado: (2023) -
Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions
por: Britz, Hannah, et al.
Publicado: (2020) -
Meta-Analysis of Food Effect on Oral Absorption of Efflux Transporter Substrate Drugs: Does Delayed Gastric Emptying Influence Drug Transport Kinetics?
por: Sharma, Sheena, et al.
Publicado: (2021) -
Impact of Albumin Binding Function on Pharmacokinetics and Pharmacodynamics of Furosemide
por: Klinkmann, Gerd, et al.
Publicado: (2022)